scanning electron microscope image shows SARS-CoV-2 (yellow)

NIAID Strategic Plan for COVID-19 Research

The NIAID Strategic Plan for COVID-19 Research details the institute’s priorities for controlling and ultimately ending the spread of the novel coronavirus (SARS-CoV-2) and the disease it causes (COVID-19).

Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient.

Researcher Access to Clinical Data

NIAID's cloud-based, secure data platform enables sharing of anonymous patient-level clinical data to help generate new knowledge to treat and prevent infectious diseases such as COVID-19.

This scanning electron microscope image shows SARS-CoV-2 (yellow)—also known as 2019-nCoV, the virus that causes COVID-19—isolated from a patient in the U.S., emerging from the surface of cells (blue/pink) cultured in the lab.

Novel Coronavirus

NIAID is conducting and supporting research on SARS CoV-2 and the disease COVID-19.

Featured Areas of Research

Diseases & Conditions

Antimicrobial Resistance
HIV/AIDS
Coronaviruses

Director, Dr. Anthony S. Fauci

About the Director

Anthony Fauci

Videocast:

NIH COVID-19 Vaccine Kick-Off Event at the NIH Clinical Center

Publication:

The Story Behind COVID-19 Vaccines

Funding Opportunities

Get the latest information on...

Learn more about...

Newsroom